Functional variants of COX-2 and risk of tobacco-related oral squamous cell carcinoma in high-risk Asian Indians

Oral Oncology

Volumn 46, Issue 8, 2010, Pages 622-626

  Mittal, Manasi ^a   Kapoor, Vaishali ^a   Mohanti, Bidhu Kalyan ^b   Das, Satya Narayan ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b INSTITUTE ROTARY CANCER HOSPITAL   (India)

Author keywords

Asian Indians; COX 2; Oral cancer; Single nucleotide polymorphism

Indexed keywords

CYCLOOXYGENASE 2;

ADULT; AGED; ARTICLE; CANCER RISK; CONTROLLED STUDY; FEMALE; GENETIC VARIABILITY; GENOTYPE; HIGH RISK POPULATION; HUMAN; INDIAN; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; ORAL SQUAMOUS CELL CARCINOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; CARCINOMA, SQUAMOUS CELL; CYCLOOXYGENASE 2; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SMOKING; TOBACCO, SMOKELESS; YOUNG ADULT;

EID: 77955509567     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2010.06.002     Document Type: Article

References (30)

1. GLOBOCAN: Cancer Incidence. Mortality and Prevalence worldwide. IARC Cancer Base No. 5, version 1.0. Lyon: IARC Press; 2002.
2. E. Fritsche, S.J. Baek, L.M. King, D.C. Zeldin, T.E. Eling, and D.A. Bell Functional characterization of COX-2 polymorphisms J Pharmacol Exp Therap 299 2001 468 476
3. G. Gasparini, R. Longo, R. Sarmiento, and A. Morabito Inhibitors of cyclooxygenase 2: a new class of anticancer agents? Lancet Oncol 4 2003 605 615
4. D.A. Kujubu, B.S. Fletcher, B.C. Varnum, R.W. Lim, and H.R. Herschman TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue J Biol Chem 266 1991 12866 12872
5. D. Moraitis, B. Du, M.S. De Lorenzo, J.O. Boyle, B.B. Weskler, and E.G. Cohen et al. Levels of cyclooxygenase-2 are increased in oral mucosa of smokers: evidence for the role of epidermal growth factor receptors and its ligands Cancer Res 65 2005 664 670
6. V. Kapoor, A.K. Singh, S. Dey, S.C. Sharma, and S.N. Das Circulating cycloxygenase-2 in patients with tobacco-related intraoral squamous cell carcinoma and evaluation of its peptide inhibitors as potential antitumor agent J Cancer Res Clin Oncol March 6 2010 [Epub ahead of print]
7. G. Pannone, P. Bufo, M.F. Caiaffa, R. Serpico, A. Lanza, and L. Lo Muzio et al. Cyclooxygenase-2 expression in oral squamous cell carcinoma Int J Immunopathol Pharmacol 17 2004 273 282
8. M. Sawhney, N. Rohatgi, J. Kaur, S. Shishodia, G. Sethi, and S.D. Gupta et al. Expression of NF kappaB parallels COX-2 expression in oral precancer and cancer: association with smokeless tobacco Int J Cancer 120 2007 2545 2556
9. O. Gallo, E. Masini, B. Bianchi, L. Bruschini, M. Paglierani, and A. Franchi Prognostic significance of cyclooxygenase-2 pathway and angiogenesis in head and neck squamous cell carcinoma Hum Pathol 33 2002 708 714
10. T. Kosaka, A. Miyata, H. Ihara, S. Hara, T. Sugimoto, and O. Takeda et al. Characterization of the human gene (PTGS2) encoding prostaglandin- endoperoxide synthase 2 Eur J Biochem 221 1994 889 897
11. X. Zhang, X. Miao, W. Tan, B. Ning, Z. Liu, and Y. Hong et al. Identification of functional genetic variants in cyclooxygenase-2 and their association with risk of esophageal cancer Gastroenterology 129 2005 565 576
12. W. Zhu, B. Wei, X. Shan, and P. Liu -765 G>C and 8473 T>C polymorphisms of COX-2 and cancer risk: a meta analysis based on 33 case control studies Mol Biol Rep 37 2009 277 288
13. S. Kuersten, and E.B. Goodwin The power of the 3′UTR: translational control and development Nat Rev Genet 4 2003 626 637
14. W.H. Peters, M. Lacko, R.H. Te Morche, A.C. Voogd, M.B. Oude Ophius, and J.J. Manni COX-2 polymorphisms and the risk for head and neck cancer in white patients Head Neck 31 2009 938 943
15. Y.C. Lin, H.I. Huang, L.H. Wang, C.C. Tsai, O. Lung, and C.Y. Dai et al. Polymorphisms of COX-2 -765G>C and p53 codon 72 and risks of oral squamous cell carcinoma in a Taiwan population Oral Oncol 44 2008 798 804
16. H.B. Nasr, K. Chahed, N. Bouaouina, and L. Chouchane PTGS (COX-2) -765G>C functional promoter polymorphism and its association with risk and lymph node metastasis in nasopharyngeal carcinoma Mol Biol Rep 36 2009 193 200
17. L.H. Sobin, Ch Wittekind, UICC, TNM classification of malignant tumors 6th ed. 2002 Wiley-Liss New York
18. M.B. Johns Jr, and J.E. Paulus-Thomas Purification of human genomic DNA from whole blood using sodium perchlorate in place of phenol Anal Biochem 180 1989 276 278
19. V. Baniasadi, N. Narain, R. Goswami, and S.N. Das Promoter region -318 C/T and -1661 A/G CTLA-4 single nucleotide polymorphisms and type 1 diabetes in north Indians Tissue Antigens 67 2006 383 389
20. J.H. Jeng, Y.J. Wang, and B.L. Chiang et al. Roles of keratinocyte inflammation in oral cancer: regulating the prostaglandin E2, interleukin-6 and TNF-α production of oral epithelial cells by areca nut extract and arecoline Carcinogenesis 24 2003 1301 1315
21. T. Wu Cycloxygenase-2 and prostaglandin signaling in cholangiocarcinoma Biochem Biophys Acta 1755 2005 135 150
22. Y.L. Konheim, and J.K. Wolford Association of a promoter variant in the inducible cyclo-oxygenase-2 gene (PTGS2) with type 2 diabetes mellitus in Pima Indians Hum Genet 113 2003 377 381
23. J. Gao, Q. Ke, H.X. Ma, Y. Wang, Y. Zhou, and Z.B. Hu et al. Functional polymorphisms in the cyclooxygenase 2 (COX-2) gene and risk of breast cancer in a Chinese population J Toxicol Environ Health A 70 2007 908 915
24. S.L. Chiang, P.H. Chen, C.H. Lee, A.M. Ko, K.W. Lee, and Y.C. Lin et al. Up-regulation of inflammatory signallings by areca nut extract and role of cyclooxygenase-2 -1195G>A polymorphism reveal risk of oral cancer Cancer Res 68 2008 8489 8498
25. R.C. Panguluri, L.O. Long, W. Chen, S. Wang, A. Coulibaly, and F. Ukoli et al. COX-2 gene promoter haplotypes and prostate cancer risk Carcinogenesis 25 2004 961 966
26. W.P. Koh, J.M. Yuan, D. van den Berg, H.P. Lee, and M.C. Yu Interaction between cyclooxygenase-2 gene polymorphism and dietary n-6 polyunsaturated fatty acids on colon cancer risk: the Singapore Chinese Health Study Brit J Cancer 90 2004 1760 1764
27. A. Papafili, M.R. Hill, D.J. Brull, R.J. McAnulty, R.P. Marshall, and S.E. Humphries et al. Common promoter variant in cyclooxygenase-2 represses gene expression: evidence of role in acute-phase inflammatory response Arterioscler Thromb Vasc Biol 22 2002 1631 1636
28. W. Szczeklik, M. Sanak, and A. Szczeklik Functional effects and gender association of COX-2 gene polymorphism G-765C in bronchial asthma J Allergy Clin Immunol 114 2004 248 253
29. J.M. Park, J.E. Choi, M.H. Chae, W.K. Lee, S.I. Cha, and J.W. Son et al. Relationship between cyclooxygenase 8473T>C pollymorphism and risk of lung cancer: a case-control study BMC Cancer 6 2006 70
30. D. Campa, M. Hashibe, D. Zaridze, N. Szeszenia-Dabrowska, I.N. Mates, and V. Janout et al. Association of common polymorphisms in inflammatory genes with risk of developing cancer of the upper aerodigestive tract Cancer Cause Control 18 2007 449 455